These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 32374006)
21. Nanoparticles Targeting Delivery Antagomir-483-5p to Bone Marrow Mesenchymal Stem Cells Treat Osteoporosis by Increasing Bone Formation. Zhou Y; Jia H; Hu A; Liu R; Zeng X; Wang H Curr Stem Cell Res Ther; 2023; 18(1):115-126. PubMed ID: 35473519 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-449b-5p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of BMSCs via targeting Satb2. Li JY; Wei X; Sun Q; Zhao XQ; Zheng CY; Bai CX; Du J; Zhang Z; Zhu LG; Jia YS Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6394-6403. PubMed ID: 31378877 [TBL] [Abstract][Full Text] [Related]
23. Circ_0019693 promotes osteogenic differentiation of bone marrow mesenchymal stem cell and enhances osteogenesis-coupled angiogenesis via regulating microRNA-942-5p-targeted purkinje cell protein 4 in the development of osteoporosis. He W; Shi X; Guo Z; Wang H; Kang M; Lv Z Bioengineered; 2022 Feb; 13(2):2181-2193. PubMed ID: 35030971 [TBL] [Abstract][Full Text] [Related]
24. Extracellular vesicles derived from T-cell acute lymphoblastic leukemia inhibit osteogenic differentiation of bone marrow mesenchymal stem cells via miR-34a-5p. Yuan T; Shi C; Xu W; Yang HL; Xia B; Tian C Endocr J; 2021 Oct; 68(10):1197-1208. PubMed ID: 34039781 [TBL] [Abstract][Full Text] [Related]
25. miR-384-5p Targets Li X; Wu J; Liu S; Zhang K; Miao X; Li J; Shi Z; Gao Y Stem Cells Dev; 2019 Jun; 28(12):791-798. PubMed ID: 30950325 [TBL] [Abstract][Full Text] [Related]
26. Low-magnitude vibration induces osteogenic differentiation of bone marrow mesenchymal stem cells via miR-378a-3p/Grb2 pathway to promote bone formation in a rat model of age-related bone loss. Yu X; Zeng Y; Bao M; Wen J; Zhu G; Cao C; He X; Li L FASEB J; 2020 Sep; 34(9):11754-11771. PubMed ID: 32652777 [TBL] [Abstract][Full Text] [Related]
27. LncRNA LINC00205 stimulates osteoporosis and contributes to spinal fracture through the regulation of the miR-26b-5p/KMT2C axis. Wang H; Xu W; Chen X; Mei X; Guo Z; Zhang J BMC Musculoskelet Disord; 2023 Apr; 24(1):262. PubMed ID: 37016415 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of miR-195-5p reduces osteoporosis through activating BMP-2/SMAD/Akt/RUNX2 pathway via targeting SMURF1. Ye LC; Qian LF; Liang L; Jiang LJ; Che ZY; Guo YH J Biol Regul Homeost Agents; 2021 Aug; 35(4):. PubMed ID: 34337910 [TBL] [Abstract][Full Text] [Related]
29. miR-765 inhibits the osteogenic differentiation of human bone marrow mesenchymal stem cells by targeting BMP6 via regulating the BMP6/Smad1/5/9 signaling pathway. Wang T; Zhang C; Wu C; Liu J; Yu H; Zhou X; Zhang J; Wang X; He S; Xu X; Ma B; Che X; Li W Stem Cell Res Ther; 2020 Feb; 11(1):62. PubMed ID: 32059748 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of dexmedetomidine regulating osteogenesis-angiogenesis coupling through the miR-361-5p/VEGFA axis in postmenopausal osteoporosis. Wang Z; Ge X; Wang Y; Liang Y; Shi H; Zhao T Life Sci; 2021 Jun; 275():119273. PubMed ID: 33631172 [TBL] [Abstract][Full Text] [Related]
31. microRNA-25-3p suppresses osteogenic differentiation of BMSCs in patients with osteoporosis by targeting ITGB3. Yu D; Li Z; Cao J; Shen F; Wei G Acta Histochem; 2022 Aug; 124(6):151926. PubMed ID: 35777302 [TBL] [Abstract][Full Text] [Related]
32. Quercetin promotes bone marrow mesenchymal stem cell proliferation and osteogenic differentiation through the H19/miR-625-5p axis to activate the Wnt/β-catenin pathway. Bian W; Xiao S; Yang L; Chen J; Deng S BMC Complement Med Ther; 2021 Sep; 21(1):243. PubMed ID: 34592982 [TBL] [Abstract][Full Text] [Related]
33. LINC01234 Sponging of the miR-513a-5p/AOX1 Axis is Upregulated in Osteoporosis and Regulates Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells. Yan Z; He Q Mol Biotechnol; 2023 Dec; 65(12):2108-2118. PubMed ID: 36964437 [TBL] [Abstract][Full Text] [Related]
34. CircRNA hsa_circ_0006859 inhibits the osteogenic differentiation of BMSCs and aggravates osteoporosis by targeting miR-642b-5p/miR-483-3p and upregulating EFNA2/DOCK3. Yin P; Xue Y Int Immunopharmacol; 2023 Mar; 116():109844. PubMed ID: 36764273 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-92b-5p modulates melatonin-mediated osteogenic differentiation of bone marrow mesenchymal stem cells by targeting ICAM-1. Li Y; Feng C; Gao M; Jin M; Liu T; Yuan Y; Yan G; Gong R; Sun Y; He M; Fu Y; Zhang L; Huang Q; Ding F; Ma W; Bi Z; Xu C; Sukhareva N; Bamba D; Reiters R; Yang F; Cai B; Yang L J Cell Mol Med; 2019 Sep; 23(9):6140-6153. PubMed ID: 31304676 [TBL] [Abstract][Full Text] [Related]
36. Icariin triggers osteogenic differentiation of bone marrow stem cells by up-regulating miR-335-5p. Teng JW; Bian SS; Kong P; Chen YG Exp Cell Res; 2022 May; 414(2):113085. PubMed ID: 35292240 [TBL] [Abstract][Full Text] [Related]
37. Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells. Chen XH; Shi ZG; Lin HB; Wu F; Zheng F; Wu CF; Huang MW Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6352-6359. PubMed ID: 31364143 [TBL] [Abstract][Full Text] [Related]
38. Simvastatin promotes osteogenic differentiation of mesenchymal stem cells in rat model of osteoporosis through BMP-2/Smads signaling pathway. Feng C; Xiao L; Yu JC; Li DY; Tang TY; Liao W; Wang ZR; Lu AQ Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):434-443. PubMed ID: 31957858 [TBL] [Abstract][Full Text] [Related]
39. MiR-21-5p regulates the dynamic of mitochondria network and rejuvenates the senile phenotype of bone marrow stromal cells (BMSCs) isolated from osteoporotic SAM/P6 mice. Sikora M; Śmieszek A; Pielok A; Marycz K Stem Cell Res Ther; 2023 Mar; 14(1):54. PubMed ID: 36978118 [TBL] [Abstract][Full Text] [Related]
40. Effect of GGCX on the differentiation function of osteoporosis bone marrow mesenchymal stem cells through regulating TGFβ/smad signaling pathway. Wang QL; Li HF; Wang DP; Liu ZY; Xiao WW; Xu LL; Yu S Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7224-7231. PubMed ID: 31539109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]